European Society of Hypertension scientific newsletter: hypertension and aortic diseases
- PMID: 22179093
- DOI: 10.1097/HJH.0b013e32834f867a
European Society of Hypertension scientific newsletter: hypertension and aortic diseases
Abstract
Hypertension, one of the major cardiovascular risk factors, promotes the formation of atheromatous lesions in the large arteries, including the aorta. It also favors aortic aneurysm and acute aortic syndrome such as aortic dissection or hematoma. In patients with aortic disease, beta-blockers and/or renin-angiotensin-aldosterone system inhibitors should be preferentially used to decrease blood pressure and improve arterial wall properties.
Comment in
-
Dihydropyridine calcium channel blocker should be mentioned for prevention of aortic consequences of arterial hypertension.J Hypertens. 2012 Jul;30(7):1487; author reply 1487-8. doi: 10.1097/HJH.0b013e328353ad88. J Hypertens. 2012. PMID: 22706393 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical